Davern Capital Partners, LP
CIK 2003147
13F filing for Q2 2026・No. 3,557
- Holdings
- US$586.54M
- Quarter change
- +US$222M
- Entries
- 15
- Net bought (estimate)
- +US$198.17M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 3
- Sold out 5
- Cut 2
- Added 10
- Corporate actions 0
- Unchanged 0
Largest holdings
15 stocks worth US$586.54M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| BNTXBIONTECH SESPONSORED ADS | Added | 754,550 | US$70.21M | 11.97% |
| ROIVROIVANT SCIENCES LTDSHS | Added | 1,932,904 | US$68.41M | 11.66% |
| RPRXROYALTY PHARMA PLCSHS CLASS A | Added | 1,155,809 | US$64.81M | 11.05% |
| IONSIONIS PHARMACEUTICALS INCCOM | Added | 798,709 | US$63.33M | 10.80% |
| INSMINSMED INCCOM PAR $.01 | Added | 559,824 | US$59.69M | 10.18% |
| REGNREGENERON PHARMACEUTICALSCOM | Added | 92,640 | US$57.76M | 9.85% |
| LEGNLEGEND BIOTECH CORPSPONSORED ADS | Cut | 1,191,522 | US$34.41M | 5.87% |
| ALNYALNYLAM PHARMACEUTICALS INCCOM | New | 113,085 | US$34.04M | 5.80% |
| NTRANATERA INCCOM | Cut | 118,975 | US$32.3M | 5.51% |
| STRUCTURE THERAPEUTICS INCSPONSORED ADS | Added | 446,059 | US$23.94M | 4.08% |
Sign in (free) to see its 15 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 13, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.